Skip to main content
Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: Targeted lipidomics analysis identified altered serum lipid profiles in patients with polymyositis and dermatomyositis

Fig. 2

Serum lipid species in patients with polymyositis or dermatomyositis before and after immunosuppressive treatment. PC, phosphatidylcholine; PE, phosphatidylethanolamine; LPC, lysophosphatidylcholine; TG, triacylglycerol. Results are expressed as percentage area (Area %) (mean ± SE): *p < 0.05 for after treatment versus before treatment

Back to article page